Category: Drug Discovery
Global Drug Discovery
-
Global Pulmonary Edema Therapeutics Market 2024-2028
... pulmonary edema therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Tourettes Syndrome Drugs Market 2024-2028
... tourettes syndrome drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Women Reproductive Health Market (2024 Edition): Analysis By Treatment Type (Menstrual Disorder, Uterine Fibroids/ Endometriosis, Infertility, Menopausal Disorder), By Route of Administration, By End User, By Region: Market Insights and Forecast (2020-2030)
... Azoth Analytics has released a research report titled “Global Women Reproductive Health Market (2024 Edition)” which provides a complete analysis of the Global Women Reproductive Health industry in terms of market segmentation by Treatment Type ... Read More
-
Drug Discovery Technologies Global Market Opportunities And Strategies To 2033
... Companies; Biopharmaceutical Companies; Biotechnology Companies; Research Institutes4) By Disease Application: Cancer Diseases; Immunological Diseases; Neurological Diseases; Cardiovascular DiseasesCovering: AstraZeneca plc.; Merck KGaA; GlaxoSmithKline Plc; Pfizer Inc.; Thermo Fisher Scientific Drug Discovery Technologies Global Market Opportunities ... Read More
-
Microscopy Market Size, Share & Trends by Product (Microscope, Software, Accessories), Type (Optical (Stereo, Confocal), Electron (SEM, TEM, Cryo-EM), AFM, STM), End User (Semiconductor, Academia, Life Science: Diagnostic, Drug Discovery, MFG) - Region Global Forecast to 2029
... to 2029 The global microscopy market is estimated to reach USD 10.6 billion by 2029 from USD 8.1 billion in 2024, at a CAGR of 5.4% during the forecast period of 2024 to 2029. The ... Read More
-
Global Cancer Immunotherapy Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Liver Cancer Drugs
... by 2030, growing at a CAGR of 18.4% over the analysis period 2023-2030. Targeted Drug Therapy, one of the segments analyzed in the report, is expected to record a 18.5% CAGR and reach US$5.1 Billion ... Read More
-
Global Schizophrenia Drugs Market Report by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) Treatment (Injectable, Oral) Therapeutic Class (Second Generation, Third Generation, Others) Countries and Company Analysis, 2024-2032
... drugs market will increase from US$ 7,433.1 million in 2030 to over US$ 10,132.4 million by 2032 with a CAGR of 3.50% from 2024 to 2032. This growth is as a result of the growing ... Read More
-
High Content Screening (HCS)
... reach US$2.2 Billion by 2030, growing at a CAGR of 9.1% over the analysis period 2023-2030. HCS Instruments, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach ... Read More
-
Biosimulation Technology
... at a CAGR of 15.7% over the analysis period 2023-2030. Biosimulation Software, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$5.7 Billion by the end of ... Read More
-
Acute Heart Failure (AHF) Therapeutics
... is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 21.3% over the analysis period 2023-2030. Cardiac Glycosides, one of the segments analyzed in the report, is expected to record a 21.8% ... Read More
-
Bipolar Disorder Therapeutics
... by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Antipsychotic Drugs, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$3.5 Billion by ... Read More
-
Drug Discovery Technologies
... by 2030, growing at a CAGR of 8.7% over the analysis period 2023-2030. Small Molecule Drugs Discovery Technologies, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach ... Read More
-
Chiral Technology
... at a CAGR of 3.8% over the analysis period 2023-2030. Intermediates, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$8.2 Billion by the end of the ... Read More
-
Synthetic Biology
... at a CAGR of 28.0% over the analysis period 2023-2030. Oligonucleotides & Synthetic DNA, one of the segments analyzed in the report, is expected to record a 29.3% CAGR and reach US$39.5 Billion by the ... Read More
-
Narcolepsy Therapeutics
... at a CAGR of 7.2% over the analysis period 2023-2030. Narcolepsy with Cataplexy Therapeutics, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$1.9 Billion by the ... Read More
-
Testosterone Replacement Therapy (TRT)
... reach US$2.5 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2023-2030. TRT Topicals, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach ... Read More
-
Irritable Bowel Syndrome (IBS) Therapeutics
... is expected to reach US$3.4 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2023-2030. IBS-D Therapeutics, one of the segments analyzed in the report, is expected to record a 6.9% ... Read More
-
Fibromyalgia Therapeutics
... at a CAGR of 3.0% over the analysis period 2023-2030. Antiepileptics Drug Class, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$2.1 Billion by the end ... Read More
-
Apoptosis
... of 4.6% over the analysis period 2023-2030. Apoptosis Assay Kits, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$3.9 Billion by the end of the analysis ... Read More
-
Anemia Drugs
... at a CAGR of 4.1% over the analysis period 2023-2030. Iron Deficiency Anemia Drugs, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$7.4 Billion by the ... Read More
-
Label-Free Detection
... at a CAGR of 7.0% over the analysis period 2023-2030. Label-Free Detection Instruments, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.4 Billion by the end ... Read More
-
Colorectal Cancer Therapeutics
... by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$14.9 Billion by ... Read More
-
Nuclear Medicine Market Size, Share & Trends Analysis Report By Product (Diagnostics (SPECT, PET), Therapeutics (Alpha Emitters, Beta Emitters)), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
... & Trends The global nuclear medicine market size is expected to reach USD 34.51 billion by 2030, registering a CAGR of 11.69% from 2024 to 2030, according to a new report by Grand View Research, ... Read More
-
Acute Coronary Syndrome
... by 2030, growing at a CAGR of 10.5% over the analysis period 2023-2030. The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 16.4% CAGR The Acute Coronary Syndrome market ... Read More
Research Assistance
